Výsledky vyhledávání - "Bhagwan S Sharma"

Akademický článek

Development of quality control parameters for classical ayurvedic formulation: Vyoshadi Churna

Autor: Anupam Kumar Mangal, Rinku Tomer, Heena Jindal, Jyoti Dahiya, Shyam Baboo Prasad, Harjeet Singh, Bhagwan S Sharma, Narayanam Srikant

Publikováno v: Journal of Ayurveda, Vol 17, Iss 1, Pp 38-44 (2023)

Introduction: Ayurvedic formulations have a long history of use and have increased amazingly to follow the global interest in natural products. However, for many classical ayurvedic formulations, no quality parameters of standardization are available

Externí odkaz: https://doaj.org/article/88a9eb16ef994d98906e37886c93130d

Zobrazit plný text záznamu

Akademický článek

AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India

Autor: Harbans Singh, Sumit Srivastava, Babita Yadav, Amit K. Rai, Sophia Jameela, Sanuj Muralidharan, Rijin Mohan, Shikha Chaudhary, Richa Singhal, Rakesh Rana, Shruti Khanduri, Bhagwan S. Sharma, Bhogavalli Chandrasekhararao, Narayanam Srikanth, Sarika Chaturvedi

Publikováno v: Complementary Therapies in Medicine, Vol 66, Iss , Pp 102814- (2022)

Objective: To determine the therapeutic efficacy and safety of AYUSH-64 as an add-on to standard care in mild to moderate COVID-19. Design setting, and interventions: This open-label randomized controlled parallel-group trial was conducted at a desig

Externí odkaz: https://doaj.org/article/d455e73e7fc749469f5e68a32bdaaed3

Zobrazit plný text záznamu

Ayurveda formulation AYUSH 64 in asymptomatic and mild COVID 19 infection-A prospective, open label Clinical Study

Autor: Manoj Shamkumar, Shiv Shankar, Babita Yadav, Sujata Rajan, Nitin Jindal, Lalita Sharma, Rakesh Kumar Rana, Richa Singhal, Shruti Khanduri, Bhagwan S Sharma, Bhogavalli Chandrasekhararao, N. Srikanth, null Bharti, null K.S.Dhiman, R. K. Manchanda

BackgroundCOVID 19 pandemic has evolved as a unique unprecedented global health crisis that has affected severely the economies and daily lives of people. Despite the diligent worldwide efforts to contain it, there is an exponential rise in cases. As

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0223dbad4b4974452ac842f4371d4d2a
https://doi.org/10.31219/osf.io/6xa9u

Zobrazit plný text záznamu

AYUSH-64 as an adjunct to Standard Care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India

Autor: Harbans Singh, Sumit Shrivastva, Babita Yadav, Amit Kumar Rai, Sophia Jameela, Sanuj Muralidharan, Rijin Mohan, Shikha Chaudhary, Richa Singhal, Rakesh Kumar Rana, Shruti Khanduri, Bhagwan S Sharma, Bhogavalli Chandrasekhararao, N. Srikanth, Sarika Chaturvedi

Publikováno v: Complementary Therapies in Medicine, Vol 66, Iss, Pp 102814-(2022)

Background: There is limited evidence on the safety and efficacy of administering Ayurveda interventions as add-on to the standard care for COVID-19. Objective: To explore the therapeutic efficacy and safety of AYUSH-64 as an add-on to standard care

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf48038e93f286fafc3bca731b744d8c
https://doi.org/10.31219/osf.io/xyuas

Zobrazit plný text záznamu

Effect of an Ayurvedic intervention (Ayush-64) in mild to moderate COVID-19: An exploratory prospective single arm clinical trial

Autor: null N.R.Singh, Amit Madan, Babita Yadav, Arun Gupta, Rakesh Kumar Rana, Vishakha Rajesh Wetal, Neha Dubey, Sophia Jameela, Richa Singhal, Shruti Khanduri, Bhagwan S Sharma, Bhogavalli Chandrasekhararao, null Bharti, N. Srikanth, null K.S.Dhiman

Background: Ayush-64 is an Ayurvedic formulation, developed and patented by Central Council of Research in Ayurvedic Sciences (CCRAS). In the present study, we repurposed it for use in mild to moderate COVID-19 cases based on a pilot study against In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0dbd9c4a51b32206a0af9bbeaab3244b
https://doi.org/10.31219/osf.io/azb9t

Zobrazit plný text záznamu

An Open label prospective interventional study to assess the prophylactic effect of Guduchi Ghan Vati in COVID-19: A community-based study in a containment zone of Himachal Pradesh, India

Autor: Vyas Kavita, Chandla Anubha, Nariyal Vikas, Babita Yadav, Azeem Ahmed, Shobhit Kumar, Hetalben Amin, Rakesh Kumar Rana, Arunabh Tripathi, Munesh Kumar, Shruti Khanduri, Bhagwan S Sharma, Vaneeta Negi, Bhogavalli Chandrasekhararao, N. Srikanth, Kartar Singh Dhiman

Background: Outbreak of SARS-CoV-2 is Janapadoddhwamsa Vikara (epidemic disease) in Ayurveda, where Rasayana drugs (immunomodulators or rejuvenating therapy) have been advocated for controlling the diseases. Therefore, Guduchi Ghan Vati, containing a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::833fb958f303ad8a16843d788a85fc69
https://doi.org/10.31219/osf.io/8vwsy

Zobrazit plný text záznamu

AYUSH-64 as add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial

Autor: R. Govind Reddy, Rajesh V Gosavi, Babita Yadav, Amit Kumar Rai, Madhuri P Holay, Manisha Talekar, Sophia Jameela, Bhagwan S Sharma, Shruti Khanduri, Rakesh Rana, Arunabh Tripathi, Bhogavalli Chandrasekhararao, N. Srikanth, Kartar Singh Dhiman

Background: The evidence on the efficacy and safety of Ayurveda interventions as add-on to the standard conventional care for COVID-19 is limited. This study was planned to explore the potential of AYUSH-64 as add-on to conventional care in improving

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a3031ed52b371ba9e02fecc8e20b95ac
https://doi.org/10.31219/osf.io/pgraf

Zobrazit plný text záznamu

Efficacy and safety of Guduchighan Vati in asymptomatic and mild to moderate cases of COVID-19: A randomized controlled pilot study

Autor: Umesh Shukla, Nitin Ujjaliya, Pankaj Gupta, Vivek Khare, Babita Yadav, Amit Kumar Rai, Hetalben Amin, Rakesh Rana, Arunabh Tripathi, Bhagwan S Sharma, Shruti Khanduri, Bhogavalli Chandrasekhararao, N. Srikanth, Kartar Singh Dhiman

Background: Currently, there is no approved treatment for the management of COVID-19 pandemic. Drug repurposing of existing medications could be a possible way to find out a novel therapeutic entity to combat the COVID-19.Objectives: To determine the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aee5e2e2c4826e56c76330f7293afaaf
https://doi.org/10.31219/osf.io/c8f9h

Zobrazit plný text záznamu

A Diffusion-Augmented Level Set Method with Efficient Two Step Implementation

Autor: Rinku K. Solanki, Bhagwan S. Sharma, Naitik D. Kapadia

Publikováno v: International Journal of Computer Applications. 70:29-34

The level set method was devised by Osher and Sethian [2] in as a simple and versatile method for computing and analyzing the motion of an interface Γ in two or three dimensions. Γ bounds a region Ω. The goal is to compute and analyze the subseque

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::da12d139904e569f2d7776f41c840248
https://doi.org/10.5120/12209-8184

Zobrazit plný text záznamu

Hypertonic (3%) saline vs 0.93% saline nebulization for acute viral bronchiolitis: a randomized controlled trial

Autor: Bhagwan S, Sharma, Mukesh K, Gupta, Shaikh P, Rafik

Publikováno v: Indian pediatrics. 50(8)

To compare the length of hospital stay (primary) and improvement in clinical severity scores (secondary) among children with bronchiolitis nebulized with 3 % hypertonic saline or 0.9% saline.Randomized double blind controlled trial.Tertiary care teac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::10f7587c8cb6d3f130434b692f2e7482
https://pubmed.ncbi.nlm.nih.gov/24036637

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání